Systemic Sclerosis

Consensus-based recommendations for the management of juvenile localised scleroderma
Francesco Zulian, Roberta Culpo, Francesca Sperotto, Jordi Anton, Tadej Avcin, Eileen M Baildam, Christina Boros, Jeffrey Chaitow, Tamàs Constantin, Ozgur Kasapcopur, Sheila Knupp Feitosa de Oliveira, Clarissa A Pilkington, Ricardo Russo, Natasa Toplak, Annet van Royen, Claudia Saad Magalhães, Sebastiaan J Vastert, Nico M Wulffraat, Ivan Foeldvari

Annals of the Rheumatic Diseases Aug 2019, 78 (8) 1019-1024; DOI: 10.1136/annrheumdis-2018-214697
Anti-Ku syndrome with elevated CK and anti-Ku syndrome with anti-dsDNA are two distinct entities with different outcomes
Lionel Spielmann, Benoit Nespola, François Séverac, Emmanuel Andres, Romain Kessler, Aurélien Guffroy, Vincent Poindron, Thierry Martin, Bernard Geny, Jean Sibilia, Alain Meyer

Annals of the Rheumatic Diseases Aug 2019, 78 (8) 1101-1106; DOI: 10.1136/annrheumdis-2018-214439
Short lymphocyte, but not granulocyte, telomere length in a subset of patients with systemic sclerosis
Katja Lakota, Vidya Sagar Hanumanthu, Rishi Agrawal, Mary Carns, Mary Armanios, John Varga

Annals of the Rheumatic Diseases Aug 2019, 78 (8) 1142-1144; DOI: 10.1136/annrheumdis-2018-214499
Unmet need in rheumatology: reports from the Targeted Therapies meeting 2018
Kevin L Winthrop, Michael E Weinblatt, Mary K Crow, Gerd R Burmester, Philip J Mease, Alexander K So, Vivian Bykerk, Ronald F Van Vollenhoven, Maxime Dougados, Jonathan Kay, Xavier Mariette, Joachim Sieper, Fritz Melchers, Bruce N Cronstein, Ethan Shevach, Ferdinand C Breedfeld, Joachim Kalden, Josef S Smolen, Daniel E Furst

Annals of the Rheumatic Diseases Jul 2019, 78 (7) 872-878; DOI: 10.1136/annrheumdis-2018-214280
Outcomes of patients with systemic sclerosis treated with rituximab in contemporary practice: a prospective cohort study
Muriel Elhai, Marouane Boubaya, Oliver Distler, Vanessa Smith, Marco Matucci-Cerinic, Juan José Alegre Sancho, Marie-Elise Truchetet, Yolanda Braun-Moscovici, Florenzo Iannone, Pavel I Novikov, Alain Lescoat, Elise Siegert, Ivan Castellví, Paolo Airó, Serena Vettori, Ellen De Langhe, Eric Hachulla, Anne Erler, Lidia Ananieva, Martin Krusche, F J López-Longo, Jörg H W Distler, Nicolas Hunzelmann, Anna-Maria Hoffmann-Vold, Valeria Riccieri, Vivien M Hsu, Maria R Pozzi, Codrina Ancuta, Edoardo Rosato, Carina Mihai, Masataka Kuwana, Lesley Ann Saketkoo, Carlo Chizzolini, Roger Hesselstrand, Susanne Ullman, Sule Yavuz, Simona Rednic, Cristian Caimmi, Coralie Bloch-Queyrat, Yannick Allanore

Annals of the Rheumatic Diseases Jul 2019, 78 (7) 979-987; DOI: 10.1136/annrheumdis-2018-214816
Development and validation of the Scleroderma Clinical Trials Consortium Damage Index (SCTC-DI): a novel instrument to quantify organ damage in systemic sclerosis
Nava Ferdowsi, Molla Huq, Wendy Stevens, Marie Hudson, Mianbo Wang, Tien Tay, Jodie L Burchell, Sam Mancuso, Candice Rabusa, Vijaya Sundararajan, David Prior, Susanna M Proudman, Murray Baron, Mandana Nikpour

Annals of the Rheumatic Diseases Jun 2019, 78 (6) 807-816; DOI: 10.1136/annrheumdis-2018-214764
Compendium of skin molecular signatures identifies key pathological features associated with fibrosis in systemic sclerosis
Su-Jin Moon, Jung Min Bae, Kyung-Su Park, Ilias Tagkopoulos, Ki-Jo Kim

Annals of the Rheumatic Diseases Jun 2019, 78 (6) 817-825; DOI: 10.1136/annrheumdis-2018-214778
Validity of the Swedish version of the systemic sclerosis quality of life questionnaire (SSCQoL): A novel measure of quality of life for patients with systemic sclerosis
Gunnel Sandqvist, Roger Hesselstrand

Annals of the Rheumatic Diseases Jun 2019, 78 (6) 855-857; DOI: 10.1136/annrheumdis-2018-214260
Evaluation of retinal microvascular perfusion in systemic sclerosis: a case–control study
Matthias Rothe, Felix Rommel, Sebastian Klapa, Jens Y Humrich, Relana Nieberding, Tanja Lange, Jan A M Sochurek, Pauline Plöttner, Salvatore Grisanti, Gabriela Riemekasten, Mahdy Ranjbar

Annals of the Rheumatic Diseases Jun 2019, 78 (6) 857-858; DOI: 10.1136/annrheumdis-2018-214541
Histone modifications underlie monocyte dysregulation in patients with systemic sclerosis, underlining the treatment potential of epigenetic targeting
Maarten van der Kroef, Monica Castellucci, Michal Mokry, Marta Cossu, Marianna Garonzi, Lara M Bossini-Castillo, Eleni Chouri, Catharina G K Wichers, Lorenzo Beretta, Elena Trombetta, Sandra Silva-Cardoso, Nadia Vazirpanah, Tiago Carvalheiro, Chiara Angiolilli, Cornelis P J Bekker, Alsya J Affandi, Kris A Reedquist, Femke Bonte-Mineur, Els J M Zirkzee, Flavia Bazzoni, Timothy R D J Radstake, Marzia Rossato

Annals of the Rheumatic Diseases Apr 2019, 78 (4) 529-538; DOI: 10.1136/annrheumdis-2018-214295

Main menu

Systemic Sclerosis

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Systemic Sclerosis

Pages